glp 1 and ibs Circulating GLP‐1 is depressed in IBS‐D samples. A, The box whisker GLP-1 Medications & Your Gut:

Nutrients (2020) 12:334

Potential Reasons to Consider Saxenda Insurance considerations: Your insurance covers Saxenda but not semaglutide Prior authorization requirements differ Step therapy requires trying Saxenda first Previous experience: Youve had success with Saxenda before You know you tolerate liraglutide well Youre continuing existing treatment Specific medical situations: Your provider has specific reasons to prefer liraglutide You have conditions that favor one medication over the other Part of a comprehensive treatment plan designed around liraglutide Personal preference: You strongly prefer daily dosing (some patients find this easier to remember) You want the FDA-approved weight loss indication specifically When Semaglutide Is Almost Always Better For most patients, semaglutide is preferable: Greater effectiveness: Nearly twice the weight loss makes a substantial difference in outcomes

What ended in 2025 was the mass-market compounding of copies of the brand drugs, which is a different thing entirely

Stay curious

A study published in JAMA Network Open , June 3, 2024 found that: In this randomized clinical trial, the combination of exercise and liraglutide [ Victoza , Saxenda ] was the most effective weight loss strategy while preserving bone health

KFF health tracking poll May 2024: The publics use and views of GLP-1 drugs, KFF (2024) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) GLP-1: Molecular mechanisms and outcomes of a complex signaling system, Neurochemistry International (2019) FDA approves Ozempic for cardiovascular risk reduction in adults with Type 2 diabetes and known heart disease, PR Newswire (2020) Dr